Full Text View
Tabular View
No Study Results Posted
Related Studies
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia
This study has been completed.
Study NCT00292071   Information provided by Merck
First Received: February 14, 2006   Last Updated: October 26, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fungal Infection
Additional conditions recognized in this trial
Infection
Mycoses
Neutropenia
More general conditions related to this trial
Agranulocytosis
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Interventions listed in this trial
caspofungin acetate
Additional drug interventions recognized in this trial
Caspofungin
Echinocandins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services